Company profile AVTX
After 39 days of this quarter the interest is at 87.0. Based on that we can calculate that during remaining 52 days it will total up to 203.0. Avalo Therapeutics expected interest is significantly lower compared to previous quarter (-61.7%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 88 | 0 -100.0% QoQ | 44 inf% QoQ | 69 56.8% QoQ |
| 2020 | 104 18.2% YoY 50.7% QoQ | 189 inf% YoY 81.7% QoQ | 99 125.0% YoY -47.6% QoQ | 76 10.1% YoY -23.2% QoQ |
| 2021 | 206 98.1% YoY 171.1% QoQ | 65 -65.6% YoY -68.4% QoQ | 161 62.6% YoY 147.7% QoQ | 211 177.6% YoY 31.1% QoQ |
| 2022 | 282 36.9% YoY 33.6% QoQ | 169 160.0% YoY -40.1% QoQ | 209 29.8% YoY 23.7% QoQ | 49 -76.8% YoY -76.6% QoQ |
| 2023 | 163 -42.2% YoY 232.7% QoQ | 103 -39.1% YoY -36.8% QoQ | 428 104.8% YoY 315.5% QoQ | 530 981.6% YoY 23.8% QoQ |
| 2024 | 87 -46.6% YoY -83.6% QoQ | - | - | - |
The average 5 years interest of Avalo Therapeutics was 12.77 per week. The last year interest of Avalo Therapeutics compared to the last 5 years has changed by 94.99%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 446.05%.
There is not enough data for AVTX-002 to provide analysis
There is not enough data for AVTX-002 to provide correlation calculation
There is not enough data for AVTX-002 to provide analysis
There is not enough data for AVTX-008 to provide analysis
There is not enough data for AVTX-008 to provide correlation calculation
There is not enough data for AVTX-008 to provide analysis
There is not enough data for AVTX-803 to provide analysis
There is not enough data for AVTX-803 to provide correlation calculation
There is not enough data for AVTX-803 to provide analysis
After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 25 |
| 2019 | 0 -100.0% QoQ | 100 inf% QoQ | 78 -22.0% QoQ | 136 444.0% YoY 74.4% QoQ |
| 2020 | 79 inf% YoY -41.9% QoQ | 79 -21.0% YoY 0.0% QoQ | 229 193.6% YoY 189.9% QoQ | 294 116.2% YoY 28.4% QoQ |
| 2021 | 185 134.2% YoY -37.1% QoQ | 188 138.0% YoY 1.6% QoQ | 100 -56.3% YoY -46.8% QoQ | 168 -42.9% YoY 68.0% QoQ |
| 2022 | 58 -68.6% YoY -65.5% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of Avalo Therapeutics stock was 6.59 per week. The last year interest of Avalo Therapeutics stock compared to the last 5 years has changed by -100.0%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -100.0%.
There is not enough data for Avalo Therapeutics career to provide analysis
There is not enough data for Avalo Therapeutics career to provide correlation calculation
There is not enough data for Avalo Therapeutics career to provide analysis
There is not enough data for Avalo Therapeutics clinical trials to provide analysis
There is not enough data for Avalo Therapeutics clinical trials to provide correlation calculation
There is not enough data for Avalo Therapeutics clinical trials to provide analysis
There is not enough data for Avalo Therapeutics COVID-19 to provide analysis
There is not enough data for Avalo Therapeutics COVID-19 to provide correlation calculation
There is not enough data for Avalo Therapeutics COVID-19 to provide analysis
Google Trends for Avalo Therapeutics immune dysregulation
Not enough data for reliable calculations!
There is not enough data for Avalo Therapeutics immune dysregulation to provide analysis
There is not enough data for Avalo Therapeutics immune dysregulation to provide correlation calculation
There is not enough data for Avalo Therapeutics immune dysregulation to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Avalo Therapeutics news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 81 | 33 -59.3% QoQ | 30 -9.1% QoQ | 86 186.7% QoQ |
| 2020 | 90 11.1% YoY 4.7% QoQ | 203 515.2% YoY 125.6% QoQ | 0 -100.0% YoY -100.0% QoQ | 212 146.5% YoY inf% QoQ |
| 2021 | 235 161.1% YoY 10.8% QoQ | 159 -21.7% YoY -32.3% QoQ | 97 inf% YoY -39.0% QoQ | 71 -66.5% YoY -26.8% QoQ |
| 2022 | 191 -18.7% YoY 169.0% QoQ | 65 -59.1% YoY -66.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 53 -25.4% YoY inf% QoQ |
| 2023 | 99 -48.2% YoY 86.8% QoQ | 39 -40.0% YoY -60.6% QoQ | 57 inf% YoY 46.2% QoQ | 69 30.2% YoY 21.1% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Avalo Therapeutics news was 7.16 per week. The last year interest of Avalo Therapeutics news compared to the last 5 years has changed by -36.87%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 2.26%.